Inventor · disambiguated record
Zijian Guo
Also filed as: GUO ZIJIAN
6 granted patents·10 pending applications·12 citations·filing 2001–2022
76Inventor score
Files withAEGERION PHARMACEUTICALS INC3ERICKSON MARY3AMRYT PHARMACEUTICALS INC2AMYLIN PHARMACEUTICALS LLC2CALIFORNIA INST OF TECHN2
Top patents by PatentIndex Score
16 records- 0179US2023115655A1Engineered polypeptides having enhanced duration of actionAMRYT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0278US9593154B2Engineered polypeptides having enhanced duration of actionAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted Mar 14, 2017·4 cites·10 claims
- 0374US9382304B2Engineered polypeptides having enhanced duration of action with reduced immunogenicityERICKSON MARY·Filed 2012·Granted Jul 5, 2016·6 cites·11 claims
- 0470US9879063B2Engineered polypeptides having enhanced duration of action and reduced immunogenicityAEGERION PHARMACEUTICALS INC·Filed 2015·Granted Jan 30, 2018·1 cites·14 claims
- 0568US11535659B2Engineered polypeptides having enhanced duration of actionAMRYT PHARMACEUTICALS INC·Filed 2020·Granted Dec 27, 2022·0 cites·8 claims
- 0661US7098007B2Cloning and functional assays of Xenopus ATRCALIFORNIA INST OF TECHN·Filed 2002·Granted Aug 29, 2006·1 cites·11 claims
- 0755US2013274182A1Engineered polypeptides having enhanced duration of actionASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 0854US2016137709A1Engineered polypeptides having enhanced duration of actionAEGERION PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0953US6593110B2Checkpoint-activating oligonucleotidesCALIFORNIA INST OF TECHN·Filed 2001·Granted Jul 15, 2003·0 cites·8 claims
- 1053US2004018603A1Checkpoint-activating oligonucleotidesFiled 2003·Application pending·0 cites
- 1152US2018305430A1Engineered Polypeptides Having Enhanced Duration of Action and Reduced ImmunogenicityAEGERION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1250US2005187147A1Compositions and methods for increasing drug efficiencyFiled 2004·Application pending·0 cites
- 1348US2006234909A1Compositions and methods for increasing drug efficiencyNEWMAN MICHAEL J·Filed 2006·Application pending·0 cites
- 1448US2014256621A1Engineered poypeptides having enhanced duration of action and reduced immunogenicityERICKSON MARY·Filed 2012·Application pending·0 cites
- 1543US2017114114A1Engineered polypeptides having enhanced duration of actionAMYLIN PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 1636US2018344813A1Engineered polypeptides having enhanced duration of action with reduced immunogenicityERICKSON MARY·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zijian Guo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →